Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8

general

Stage IVA includes: (T4a, N2, M0, Any G); (T4b, N0-2, M0, Any G); (Any T, N3, M0, Any G). T4a: Tumor invades the pleura, pericardium, azygos vein, diaphragm, or peritoneum. T4b: Tumor invades other adjacent structures, such as the aorta, vertebral body, or airway. N0: No regional lymph node metastasis. N1: Tumor with metastasis in one or two regional lymph nodes. N2: Tumor with metastasis in three to six regional lymph nodes. N3: Tumor with metastasis in seven or more regional lymph nodes. M0: N

18

Centers

14

Active Trials

Cancer Funding

Top Centers for Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8(18)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
High-Volume Research Center
74.0
2
NCI Comprehensive
Active Research Program
57.8
3
NCI Comprehensive
Active Research Program
57.8
4
NCI Comprehensive
Active Research Program
57.8
557.8
6
NCI Comprehensive
Active Research Program
57.8
7
NCI Comprehensive
Active Research Program
57.8
8
Active Research Program
57.8
9
NCI Comprehensive
Active Research Program
57.8
10
NCI Clinical
Active Research Program
57.8
11
Active Research Program
57.8
12
Active Research Program
57.8
13
Active Research Program
57.8
14
NCI Comprehensive
36.5
1536.5
1636.5
1736.5
1836.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →